Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vibha Sharma

Vibha Sharma is a senior reporter covering pharmaceutical and medtech regulatory developments across the globe. She joined Scrip Regulatory Affairs in September 2010 and has since then been at the center of deciding and writing news on important regulatory issues affecting the pharma and medtech sectors and explaining their implications for the industry.

Her fields of interest include the EU Pharmacovigilance legislation and the EU Paediatrics Regulation on which she has written several exclusive articles from various industry conferences. She has also commissioned some pieces of expert analysis on major developments in the pharma and medtech regulatory arenas.

Before joining Informa, she was principal correspondent with India's national newspaper Hindustan Times, where she reported on health and medical issues, besides several other topics. She has also worked with two other Indian national dailies, The Indian Express and The Asian Age.



Latest From Vibha Sharma

EMA Offers ‘Dynamic Demo’ Of New Clinical Trials Portal

The European Medicines Agency will hold a webinar to explain and demonstrate specific functionalities of the new clinical trials system relevant to clinical trial sponsors. 

Europe Clinical Trials

UK MHRA Explains Procedures For On-Site Inspections In COVID-19 Context

New guidance explains how UK-based sites and organizations can facilitate routine on-site good practice inspections that are due to restart next month.

United Kingdom Compliance

Canada Asks Insulin Makers To Rectify Inconsistent Product Monographs

A class review of Canadian product monographs for various insulin products has revealed inconsistencies.

Canada Biologics

Australia Moves To Further Improve Advertising Framework

A review of therapeutic goods advertising reforms that were introduced in Australia in 2018 calls for further changes to support implementation and compliance.

Australia Moves To Further Improve Advertising Framework

A review of therapeutic goods advertising reforms that were introduced in Australia in 2018 calls for further changes to support implementation and compliance.

Australia Advertising, Marketing & Sales

Companies Get Yet More Time To Assess Nitrosamine Risk In EU

After EU regulators decided that biological medicines should be reviewed for the presence of possible nitrosamine impurities – as is already required for chemical medicines – new deadlines have been agreed on to give companies enough time to comply.

Europe Manufacturing
See All
UsernamePublicRestriction

Register